RESÚMENES FEBRERO 2009

.

Child & Adolescent Disorders

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana (algunos artículos requieren ir a la tabla de contenidos del número actual de la revista)

 

3 - Age-related grey matter volume correlates of response inhibition and shifting in attention-deficit hyperactivity disorder

Grainne M. McAlonan, Vinci Cheung, Siew E. Chua, Jaap Oosterlaan, Se-fong Hung, Chun-pan Tang, Chi-chiu Lee, Shi-leung Kwong, Ting-pong Ho, Charlton Cheung, John Suckling, Patrick W. L. Leung

The British Journal of Psychiatry (2009) 194: 123-129

5 - Efficacy, safety and tolerability of two dosing regimens in adolescent schizophrenia: double-blind study

Magali Haas, Mariëlle Eerdekens, Stuart Kushner, Julia Singer, Ilse Augustyns, Jorge Quiroz, Gahan Pandina, Vivek Kusumakar

The British Journal of Psychiatry (2009) 194: 158-164

3 - Adolescent-onset anorexia nervosa: 18-year outcome

Elisabet Wentz, I. Carina Gillberg, Henrik Anckarsäter, Christopher Gillberg, Maria Råstam

The British Journal of Psychiatry (2009) 194: 168-174

GRATIS 3! - Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies

Corrado Barbui, Eleonora Esposito, and Andrea Cipriani

CMAJ • February 3, 2009; 180 (3)

3 - Polypharmacy in Children and Adolescents Treated for Major Depressive Disorder: A Claims Database Study

Roger S. McIntyre, and Jeanette M. Jerrell

J Clin Psychiatry January 27, 2009: e1-e7

 

3! - Cost implications of specific and non-specific treatment for young persons at ultra high risk of developing a first episode of psychosis

Lisa J. Phillips, Sue Cotton, Cathrine Mihalopoulos, Sophy Shih, Alison R. Yung, Rob Carter and Patrick D. McGorry

Early Intervention in Psychiatry. Volume 3 Issue 1, Pages 28 - 34

 

GRATIS 3 - Methylphenidate improves response inhibition but not reflection–impulsivity in children with attention deficit hyperactivity disorder (ADHD)

Original Investigation

Methylphenidate improves response inhibition but not reflection–impulsivity in children with attention deficit hyperactivity disorder (ADHD)

Elise E. DeVito, Andrew D. Blackwell, Luke Clark, Lindsey Kent, Anna Maria Dezsery, Danielle C. Turner, Michael R. F. Aitken and Barbara J. Sahakian

Psychopharmacology. Volume 202, Numbers 1-3 / January, 2009: 531-539

 

GRATIS 3 - NIDA Study Shows That Methylphenidate (Ritalin) Causes Neuronal Changes in Brain Reward Areas. Similarities and Differences Compared to Cocaine were Found

Stephanie Older

NIMH News. February 2, 2009

GRATIS 3 - Maintenance treatment of adolescent bipolar disorder: open study of the effectiveness and tolerability of quetiapine

Anne Duffy, Robert Milin and Paul Grof

BMC Psychiatry 2009, 9:4

 

3 - Silent suffering: understanding and treating children with selective mutism

Katharina Manassis

Expert Review of Neurotherapeutics. February 2009, Vol. 9, No. 2, Pages 235-243

 

3! - Association between antidepressant half-life and the risk of suicidal ideation or behavior among children and adolescents: Confirmatory analysis and research implications




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Eric G. Smith

Journal of Affective Disorders. Volume 114, Issues 1-3, April 2009, Pages 143-148

 

5< - Randomised Controlled Study-efficacy of Clonidine versus Carbamazepine in Children with ADHD

Vrinda Nair and S. Mahadevan

Journal of Tropical Pediatrics, On Line, February 2009

 

5 - Omega-3/Omega-6 Fatty Acids for Attention Deficit Hyperactivity Disorder. A Randomized Placebo-Controlled Trial in Children and Adolescents

Mats Johnson, Sven Östlund, Gunnar Fransson, Björn Kadesjö, Christopher Gillberg

Journal of Attention Disorders, Vol. 12, No. 5, 394-401 (2009)

3 - Comparative Study of Children With ADHD Only, Autism Spectrum Disorder + ADHD, and Chronic Multiple Tic Disorder + ADHD

Kenneth D. Gadow, Carla J. DeVincent, Jayne Schneider

Journal of Attention Disorders, Vol. 12, No. 5, 474-485 (2009)

3! - Predictors of Spontaneous and Systematically Assessed Suicidal Adverse Events in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) Study

David A. Brent, Graham J. Emslie, Greg N. Clarke, Joan Asarnow, Anthony Spirito, Louise Ritz, Benedetto Vitiello, Satish Iyengar, Boris Birmaher, Neal D. Ryan, Jamie Zelazny, Matthew Onorato, Betsy Kennard, Taryn L. Mayes, Lynn L. DeBar, James T. McCracken, Michael Strober, Robert Suddath, Henrietta Leonard, Giovanna Porta, and Martin B. Keller

Am J Psychiatry Published February 17, 2009

3! - Mechanisms Underlying the Comorbidity Between Depressive and Addictive Disorders in Adolescents: Interactions Between Stress and HPA Activity

Uma Rao, Constance L. Hammen, and Russell E. Poland

Am J Psychiatry Published February 17, 2009

3! - Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents

Daniel Scherer, David Hassel, Ramona Bloehs, Edgar Zitron, Katharina von Löwenstern, Claudia Seyler, Dierk Thomas, Franziska Konrad, Heiner F. Bürgers, Gunnar Seemann, Wolfgang Rottbauer, Hugo A. Katus, Christoph A. Karle and Eberhard P. Scholz

British Journal of Pharmacology. 2009; Volume 156 Issue 2, Pages 226 - 236

 

3! - Neurocognitive effects of switching from methylphenidate-IR to OROS-methylphenidate in children with ADHD

Yeni Kim, Min-Sup Shin, Jae-Won Kim, Hee-Jung Yoo, Soo-Churl Cho, Boong-Nyun Kim

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 2, Pages 95 - 102

 

4 - The Safety of Olanzapine in Adolescents With Schizophrenia or Bipolar I Disorder: A Pooled Analysis of 4 Clinical Trials

Ludmila A. Kryzhanovskaya, Carol K. Robertson-Plouch, Wen Xu, Janice L. Carlson, Karen M. Merida, and Ralf W. Dittmann

J Clin Psychiatry 2009;70(2):247-258

 

GRATIS 3! - Methylphenidate-induced dendritic spine formation and ΔFosB expression in nucleus accumbens

Yong Kim, Merilee A. Teylan, Matthew Baron, Adam Sands, Angus C. Nairn and Paul Greengard

PNAS February 24, 2009 vol. 106 no. 8 2915-2920

 

3 - Maternal Smoking in Pregnancy and Externalizing Behavior in 18-Month-Old Children: Results From a Population-Based Prospective Study

STENE-LARSEN, KIM; BORGE, ANNE I.H; VOLLRATH, MARGARETE E

Journal of the American Academy of Child & Adolescent Psychiatry: March 2009 - Volume 48 - Issue 3 - pp 283-289

 

3! - Treatment of Selective Serotonin Reuptake Inhibitor-Resistant Depression in Adolescents: Predictors and Moderators of Treatment Response

RYAN, NEAL; KENNARD, BETSY; MAYES, TARYN; DEBAR, LYNN; MCCRACKEN, JAMES; STROBER, MICHAEL; SUDDATH, ROBERT; LEONARD, HENRIETTA; PORTA, GIOVANNA; KELLER, MARTIN; BRENT, DAVID; ASARNOW, JOAN ROSENBAUM; EMSLIE, GRAHAM; CLARKE, GREG; WAGNER, KAREN DINEEN; SPIRITO, ANTHONY; VITIELLO, BENEDETTO; IYENGAR, SATISH; SHAMSEDDEEN, WAEL; RITZ, LOUISE; BIRMAHER, BORIS

Journal of the American Academy of Child & Adolescent Psychiatry: March 2009 - Volume 48 - Issue 3 - pp 330-339

 

GRATIS 3! - Psychotropic Medications and Breastfeeding

Madeleine A. Becker, Geraldine F. Mayor, and Elisabeth J.S. Kunkel

Primary Psychiatry. 2009;16(3):42-51

 

GRATIS 3! - Are Selective Serotonin Reuptake Inhibitors a Risk Factor for Adolescent Suicide?

David Healy

Can J Psychiatry. 2009;54(2):69–71

 

GRATIS 3 - Selective Serotonin Reuptake Inhibitors and Suicidality: A Guide for the Perplexed

David A Brent

Can J Psychiatry. 2009;54(2):72–74

 

GRATIS 3 - Youth Depression and Suicide: Selective Serotonin Reuptake Inhibitors Treat the Former and Prevent the Latter

David A Brent

Can J Psychiatry. 2009;54(2):76–77

.

Regresar a RESÚMENES FEBRERO 2009

.

© 1999-2009 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.